Scaling up in a pandemic: A Q&A with Andy Whittle

Andy Whittle, VP Manufacturing at QuantuMDx, discusses the highs and lows of scaling up to manufacture, during a global pandemic. What is your background?  I’ve over 20 years manufacturing experience,

Share
QuantuMDx E-poster presentation: ECCVID 2020

Our Head of Assay Feasibility, Dr John Tyson presented an e-poster at ECCVID last month – the ESCMID Conference on Coronavirus. The e-poster focuses on  the independent, multi centre, clinical performance

Share
White paper: QuantuMDx SARS-CoV-2 RT-PCR Detection Assay – clinical performance evaluation

Title: QuantuMDx SARS-CoV-2 RT-PCR Detection Assay – design, analytical and multi-centre evaluation of clinical performance White paper overview: After completing the development of our SARS-CoV-2 RT-PCR Detection Assay, QuantuMDx undertook

Share
Research Scientist

We are looking for an experienced Assay Research Scientist with a strong background in molecular biology/diagnostics to take a key role in development projects, focusing on our Q-POC™ platform and

Share
Mechanical Engineer

We are looking for a skilled and experienced Mechanical Engineer to develop engineering solutions for research and commercial development across our platforms, and to liaise with partners across the globe to

Share
C++ Software Developer

We are looking for a C++ Software Developer who, as a key member of the development team, will lead and shape the software architecture for the next generation of QuantuMDx

Share
Staff Spotlight: Sam Bhatt

Sam Bhatt is a Programme Manager at QuantuMDx. Here, Sam tells us more about himself and gives us an insight into his role. When did you start working at QuantuMDx? 

Share
QuantuMDx attains CE-IVD marking for SARS-CoV-2 Test

QuantuMDx Group today announces its SARS-CoV-2 detection assay has been CE-IVD marked under the In Vitro Diagnostics Directive (98/79/EC), enabling use within the European Union. QuantuMDx has now registered the

Share
Software Test Engineer

QuantuMDx is looking for a skilled and motivated Software Test Engineer to test software for both our Q-POC™ platform and internal research platforms, in addition to liaising with our engineering and

Share
QuantuMDx launches rapid, sensitive SARS-CoV-2 test

QuantuMDx Group today announces the launch of its sensitive SARS-CoV-2 assay for laboratory use, which delivers a result in approximately 70 minutes. Working with British manufacturing partner Biofortuna Limited, QuantuMDx

Share